Atopic Dermatitis Clinical Trials
Atopic Dermatitis clinical trials study new biologics, small-molecule drugs, and treatment approaches for atopic Dermatitis and related immune or inflammatory conditions. Corterve gathers actively recruiting Atopic Dermatitis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Atopic Dermatitis studies
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisNCT07003425PHASE2Apogee Therapeutics, Inc.Fountain Valley, California
- A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaNCT07216027PHASE2PfizerHuntington Beach, California
- Cardamom and Topical Roseomonas in Atopic DermatitisNCT06096857PHASE2National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- Metabolic Profiling of Immune Responses in Immune-mediated DiseasesNCT04864886National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisNCT07298395PHASE2Enveda TherapeuticsBirmingham, Alabama
- Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic DermatitisNCT07262983PHASE1National Institute of Allergy and Infectious Diseases (NIAID)Bethesda, Maryland
- Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.NCT06899204PfizerSan Diego, California
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsNCT06564389PHASE1PfizerAnaheim, California
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaNCT06807281PHASE3PfizerBirmingham, Alabama
- Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics ProjectNCT06300697NAUniversity of MichiganAnn Arbor, Michigan
- Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisNCT05042258PHASE4Northwestern UniversityChicago, Illinois
- Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchNCT00177268University of PittsburghPittsburgh, Pennsylvania
Atopic Dermatitis trials by state
Atopic Dermatitis trials by metro
Frequently asked questions
- How do I find recruiting Atopic Dermatitis clinical trials?
- Corterve aggregates actively recruiting Atopic Dermatitis studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Atopic Dermatitis clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Atopic Dermatitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.